Stay updated on Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Footer revision label updated from Revision: v3.5.0 to Revision: v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:28:07.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Added 'Carcinoma of esophagus' to the conditions listed for the study.
    Difference
    0.1%
    Check dated 2026-04-02T00:14:40.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-25T20:24:27.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:55:06.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Gastric cancer is now listed as a condition term, and a Genetic and Rare Diseases Information Center resource has been added under Resources.
    Difference
    0.2%
    Check dated 2026-02-18T04:40:53.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2026-02-11T09:28:36.000Z thumbnail image

Stay in the know with updates to Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.